Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • BBoy
    Member
    • Oct 2010
    • 50

    #1

    Compute requirements?

    Does anyone have insight into how the higher data rates of the Mk2 devices will impact compute requirements (or even the compute requirements of Mk1)? One of the few papers that deals with this question (that I know of) is here
    http://bioinformatics.oxfordjournals...rmatics.btv046
    and here


    Unless I am mus-interpreting something in the paper, HMM is pretty computationally intensive and seems to require something on the order of 1 mid-range core for every stream of 100 bps or so. Even if this estimate is inefficient by a factor of 1000 the compute requirements of a Mk2 Minion or a Promethion look fiendish. If the devices are trully capable of "run until" as ONT claims them to be

    Minion = 3000 pores x 500 bps = 15 cores assuming that the above estimate is 1000x too slow

    Promethion = 144,000 pores x 500 bps = 720 cores, again, assuming the above estimate is 1000x too slow

    These are impossibly high numbers, so something seems off. Can any current MAP-er comment on their understanding of the compute overhead? I understand things are in the cloud so it may be difficult to guess, but roughly how long does the base calling analysis take and, if you have an idea, how many instances does it run on AWS?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
60 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
75 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Working...